Pain, opioids, and goals at end of life
An 81-year-old woman with metastatic pancreatic cancer and a prognosis of weeks is admitted to a hospice unit with severe abdominal pain. She is alert but weak, has a creatinine of 2.4 (eGFR about 20), and weighs 48 kg. She is currently on morphine 10 mg every 4 hours as needed, which gives only partial relief, plus acetaminophen. She has had two episodes of confusion after morphine doses. Her family is anxious about "morphine hastening death." She has an advance directive stating comfort-focused care.
1. How would you assess and treat her pain, and why might morphine be a poor choice here?
Read the worked answer
Assessment. Severe, likely visceral and neuropathic cancer pain; current regimen is inadequate (PRN only, partial relief). Use a validated scale and reassess regularly. Her confusion after morphine suggests accumulation of active metabolites.
Why morphine is suboptimal:
- Renal impairment (eGFR ~20): morphine's metabolites (morphine-6- and 3-glucuronide) accumulate, causing neuroexcitation (myoclonus, hyperalgesia) and prolonged sedation/confusion.
- Better options: hydromorphone or fentanyl (less renal dependence), or oxycodone with caution. Consider a scheduled long-acting opioid plus short-acting breakthrough.
Plan:
- Convert to a scheduled opioid (e.g., hydromorphone) with a breakthrough dose (roughly 10–15% of total daily dose), titrate to effect, and monitor for sedation, respiratory rate, and myoclonus.
- Add adjuvant analgesia for neuropathic component (e.g., gabapentin cautiously with renal dosing, or corticosteroids for tumor-related pain).
- Continue acetaminophen (respect maximum dose); consider nonpharmacologic comfort measures.
Monitoring. Reassess pain and side effects frequently; treat constipation prophylactically.
2. How do you address the family's fear that morphine will hasten death?
Read the worked answer
Acknowledge and educate. Explain the principle of double effect: opioids given at doses titrated to relieve pain and suffering are intended to comfort, and the goal is symptom relief, not to end life. Untreated severe pain itself causes suffering and physiologic stress.
Evidence-based reassurance: When opioids are titrated to effect for pain, they do not shorten life; they improve comfort and function. Explain that we will use the lowest effective dose and monitor closely.
Align with the advance directive. Reaffirm her stated wish for comfort-focused care and that the team will honor it. Involve palliative care and, if desired, chaplain/social work.
Communication. Use plain language, invite questions, and document the discussion. Reassure the family that comfort is the priority and that we will continue to reassess.
3. What other aspects of end-of-life care should be addressed?
Read the worked answer
Goals of care and advance directive: confirm code status (likely DNR/DNI), preferences for hospitalization, and surrogate decision-maker; document clearly.
Symptom management beyond pain: nausea (antiemetics), constipation (bowel regimen), dyspnea (opioids, oxygen if hypoxic), agitation/delirium (address causes, low-dose antipsychotic if needed), and oral care.
Psychosocial and spiritual: address family anxiety, provide social work/chaplain support, and allow family presence.
Nutrition/hydration: discuss that artificial hydration/nutrition may not improve comfort and can worsen symptoms (edema, secretions); focus on mouth care.
Care setting and team: hospice/palliative care coordination, 24-hour availability, and bereavement support for the family. Reassess goals regularly as her condition changes.